No Data
No Data
Earnings Not Telling The Story For Shanghai Haixin Group Co., Ltd. (SHSE:600851) After Shares Rise 42%
Shanghai Haixin Group's (SHSE:600851) Solid Earnings May Rest On Weak Foundations
Shanghai Haixin Group Co., Ltd. 2024 Semi-annual Report
Summary of the Semi-Annual Report of Shanghai Haixin Group Co., Ltd. for 2024
Shanghai Haixin Group (600851.SH) released its half-year performance with a 34.98% decrease in revenue and a net income of 0.102 billion yuan.
shanghai haixin group (600851.SH) released its 2024 interim report. During the reporting period, the company achieved revenue...
Shanghai Haixin Group (600851.SH): Two pharmaceutical holding companies under it currently do not produce antiviral traditional chinese medicine.
Shanghai Haixin Group (600851.SH) stated on the investor interaction platform on August 20 that its two pharmaceutical holding companies under the company currently do not produce antiviral traditional Chinese medicine.
No Data
No Data